Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth Evans

Showing results (51-60 of 749) with videos related to

Pageof 75
Sort By:
Human Mutation|April 7, 2022
Comparison of the frequency of loss-of-function LZTR1 variants between schwannomatosis patients and the general populationFanxuan Deng, D Gareth Evans, Miriam J Smith
European Journal of Cancer (Oxford, England : 1990)|December 1, 2019
New evidence confirms that reproductive risk factors can be used to stratify breast cancer risks: Implications for a new population screening paradigmD Gareth Evans, Sacha J Howell, Anthony Howell
Breast (Edinburgh, Scotland)|November 22, 2017
Psychosocial issues of a population approach to high genetic risk identification: Behavioural, emotional and informed choice issuesDavid P French, Anthony Howell, D Gareth Evans
Cancer Chemotherapy and Pharmacology|June 24, 2003
New approaches to the endocrine prevention and treatment of breast cancerAnthony Howell, Sacha J Howell, D Gareth Evans
Human Mutation|April 25, 2019
Concern regarding classification of germline TP53 variants as likely pathogenicD Gareth Evans, Clare Turnbull, Emma R Woodward
The Veterinary Record|April 11, 2019
Protect yourself, your staff and your clientsElisa Ursich, Nadine Anderson, Gareth Evans, et al.
Journal of Medical Genetics|April 19, 2023
<i>TP53</i> c.455C>T p.(Pro152Leu) pathogenic variant is a lower risk allele with attenuated risks of breast cancer and sarcomaD Gareth Evans, Elaine F Harkness, Emma R Woodward
Best Practice & Research. Clinical Obstetrics & Gynaecology|December 19, 2019
Risk-based breast cancer screening strategies in womenElaine F Harkness, Susan M Astley, D Gareth Evans
Journal of Medical Genetics|April 11, 2025
Effects of higher-than-expected control population allele frequency on classification of loss-of-function variants in cancer susceptibility genesMiriam J Smith, George J Burghel, D Gareth Evans
Journal of Medical Genetics|January 4, 2023
Differential rates of germline heterozygote and mosaic variants in <i>NF2</i> may show varying propensity for meiotic or mitotic mutationD Gareth Evans, George J Burghel, Miriam Jane Smith
Pageof 75

Showing results (51-60 of 749) with videos related to

Sort By:
Pageof 75
Human Mutation|April 7, 2022
Comparison of the frequency of loss-of-function LZTR1 variants between schwannomatosis patients and the general populationFanxuan Deng, D Gareth Evans, Miriam J Smith
European Journal of Cancer (Oxford, England : 1990)|December 1, 2019
New evidence confirms that reproductive risk factors can be used to stratify breast cancer risks: Implications for a new population screening paradigmD Gareth Evans, Sacha J Howell, Anthony Howell
Breast (Edinburgh, Scotland)|November 22, 2017
Psychosocial issues of a population approach to high genetic risk identification: Behavioural, emotional and informed choice issuesDavid P French, Anthony Howell, D Gareth Evans
Cancer Chemotherapy and Pharmacology|June 24, 2003
New approaches to the endocrine prevention and treatment of breast cancerAnthony Howell, Sacha J Howell, D Gareth Evans
Human Mutation|April 25, 2019
Concern regarding classification of germline TP53 variants as likely pathogenicD Gareth Evans, Clare Turnbull, Emma R Woodward
The Veterinary Record|April 11, 2019
Protect yourself, your staff and your clientsElisa Ursich, Nadine Anderson, Gareth Evans, et al.
Journal of Medical Genetics|April 19, 2023
<i>TP53</i> c.455C>T p.(Pro152Leu) pathogenic variant is a lower risk allele with attenuated risks of breast cancer and sarcomaD Gareth Evans, Elaine F Harkness, Emma R Woodward
Best Practice & Research. Clinical Obstetrics & Gynaecology|December 19, 2019
Risk-based breast cancer screening strategies in womenElaine F Harkness, Susan M Astley, D Gareth Evans
Journal of Medical Genetics|April 11, 2025
Effects of higher-than-expected control population allele frequency on classification of loss-of-function variants in cancer susceptibility genesMiriam J Smith, George J Burghel, D Gareth Evans
Journal of Medical Genetics|January 4, 2023
Differential rates of germline heterozygote and mosaic variants in <i>NF2</i> may show varying propensity for meiotic or mitotic mutationD Gareth Evans, George J Burghel, Miriam Jane Smith
Pageof 75